Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Corbin Davis
Authored Items
Greater Social Support May Help Alleviate Pain in Patients with Cancer
By
Corbin Davis
February 2020, Vol 10, No 2
Supportive Care 2019 Symposium
According to results from a retrospective analysis of nearly 12,000 patients with cancer, increased social support may function as an analgesic and help to mitigate pain.
Read More ›
Palliative Care Improves Pain Control with Less Opioids in Advanced Cancer
By
Corbin Davis
February 2020, Vol 10, No 2
Supportive Care 2019 Symposium
Reducing pain without increasing opioids is feasible in patients with advanced cancer, according to results presented at the 2019 ASCO Supportive Care in Oncology Symposium. In a retrospective analysis of 300 patients with advanced cancer receiving inpatient palliative care services, researchers found that nearly half of patients who achieved clinically improved pain did so without an increase in oral morphine equivalent daily dose.
Read More ›
Steroids plus Exercise Reduce Fatigue in Patients with Advanced Cancer
By
Corbin Davis
January 2020, Vol 10, No 1
2019 Supportive Care Symposium
Steroids plus exercise could be the best combination for treating fatigue in patients with advanced cancer, according to data presented at the 2019 Supportive Care in Oncology Symposium.
Read More ›
Psychosocial Issues in Patients with Cancer: It’s Time for Real-World Interventions
By
Corbin Davis
January 2020, Vol 10, No 1
2019 Supportive Care Symposium
There is no shortage of research on psychosocial issues in patients with cancer, but implementation of this evidence in clinical practice has a long way to go, according to data presented at the 2019 Supportive Care in Oncology Symposium.
Read More ›
Medical Cannabis in Patients with Advanced Cancer: Challenges Remain
By
Corbin Davis
December 2019, Vol 9, No 12
2019 Supportive Care Symposium
,
Medicinal Cannabis
Cannabis has been credited as a medicinal plant with benefits ranging from pain and inflammation relief to epileptic seizure reduction to insomnia and anxiety cures, but the evidence is still limited, particularly in the setting of advanced cancer.
Read More ›
Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery
By
Corbin Davis
May 2018, Vol 8, No 5
2018 Head and Neck Cancers Symposium
Read More ›
Cabozantinib Active as First-Line Treatment of Differentiated Thyroid Cancer
By
Corbin Davis
May 2018, Vol 8, No 5
2018 Head and Neck Cancers Symposium
Read More ›
Treatment Considerations for Relapsed or Refractory Multiple Myeloma
By
Corbin Davis
March 2018, Vol 8, No 3
Hematologic Malignancies
,
Multiple Myeloma
Despite major advances in treatment interventions, multiple myeloma remains incurable in the majority of patients, and relapse is an expected part of the disease course. At the 2017 NCCN Hematologic Malignancies Congress, Natalie S. Callander, MD, a hematologist at the University of Wisconsin Carbone Cancer Center, Madison, outlined issues in the management of relapsed or refractory multiple myeloma.
Read More ›
Survivorship Care: Managing Long-Term Side Effects of Lymphoma Treatment
By
Corbin Davis
December 2017, Vol 7, No 12
Survivorship
,
Survivorship Care
With 5-year survival rates for Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) at 86% and 71%, respectively, the number of lymphoma survivors is on the rise, but achieving long-term quality of life after treatment has ended remains a challenge. Data presented at the 2017 NCCN Hematologic Malignancies Congress reveal that treatment-related side effects cause long-term metabolic, endocrine, physical, and mental alterations that impair functional capacity.
Read More ›
Treating Newly Diagnosed Multiple Myeloma in Transplant-Eligible Patients
By
Corbin Davis
December 2017, Vol 7, No 12
Hematologic Malignancies
,
Multiple Myeloma
,
NCCN Hematologic Malignancies News
,
National Comprehensive Cancer Network (NCCN)
Recent advances in the treatment of patients with multiple myeloma have dramatically altered the trajectory of the disease, as providers now have several efficacious agents in various drug classes at their disposal. At the 2017 NCCN Hematologic Malignancies Congress, Shaji K. Kumar, MD, Division of Hematology, Mayo Clinic, Rochester, MN, provided management strategies for newly diagnosed multiple myeloma, including the role of autologous stem-cell transplant (ASCT) and posttransplant maintenance therapy.
Read More ›
Episode-of-Care Reimbursement Model in Oncology: Benefits and Challenges
By
Corbin Davis
March 2016, Vol 6, No 3
Reimbursement
Given the high cost of care for acute leukemia, innovative payment strategies that reward longitudinal care and create economic incentives for data-driven care delivery are needed, according to Joseph Alvarnas, MD, Director of Value-Based Analytics, and Associate Clinical Professor of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Out Models Cost Patients and Employers More Than They Disclose
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Best Practices: Education for Patients with Advanced NSCLC Treated with Immune Checkpoint Inhibitors
By
Marianne Davies, DNP, ACNP, AOCNP, FAAN
;
Shawn Perkins, RN, BSN, OCN
3.
Dexamethasone-Sparing Regimen Safe and Effective in Frail Patients with Multiple Myeloma
By
William King
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes